*.*.*
close

In RFK Jr., drugmakers face an antagonist with regulatory power



Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination will affect the Food and Drug Administration.



Source link : https://www.washingtonpost.com/business/2024/11/15/rfk-jr-fda-health-care-companies-trump/

Author : Daniel Gilbert, Rachel Roubein, David Ovalle

Publish date : 2024-11-15 19:37:59

Copyright for syndicated content belongs to the linked Source.

Tags :The Washington Post

..........................%%%...*...........................................$$$$$$$$$$$$$$$$$$$$--------------------.....